Arcutis Biotherapeutics Inc (ARQT)

Feb 21, 2025

(ARQT) Proactive Strategies - Stock Traders Daily

Feb 21, 2025

Feb 20, 2025

Arcutis Biotherapeutics (ARQT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

Feb 20, 2025

Feb 18, 2025

Arcutis to Present at the TD Cowen 45th Annual Health Care Conference - The Manila Times

Feb 18, 2025

Feb 18, 2025

Dermatology Leader Arcutis Takes Center Stage at Major Healthcare Conference - StockTitan

Feb 18, 2025

Feb 18, 2025

Wall Street Analysts Think Arcutis Biotherapeutics (ARQT) Could Surge 51.64%: Read This Before Placing a Bet - MSN

Feb 18, 2025

Feb 18, 2025

Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Down 9.5%Should You Sell? - MarketBeat

Feb 18, 2025

Feb 17, 2025

High Growth Tech Stocks To Watch In February 2025 - Yahoo Finance

Feb 17, 2025

Feb 16, 2025

Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Up 20%Time to Buy? - MarketBeat

Feb 16, 2025

Feb 16, 2025

Fishman Jay A Ltd. MI Acquires 118,400 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) - MarketBeat

Feb 16, 2025

Feb 14, 2025

Arcutis Biotherapeutics (ARQT) Surges 15.9%: Is This an Indication of Further Gains? - MSN

Feb 14, 2025

Feb 14, 2025

Health Care Roundup: Market Talk - MSN

Feb 14, 2025

Feb 14, 2025

Arcutis Biotherapeutics' (ARQT) Buy Rating Reaffirmed at Guggenheim - MarketBeat

Feb 14, 2025

Feb 13, 2025

Brokerages Set Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Target Price at $16.60 - MarketBeat

Feb 13, 2025

Feb 13, 2025

Arcutis Biotherapeutics jumps amid takeover speculation - MSN

Feb 13, 2025

Feb 12, 2025

Here's Why Arcutis Biotherapeutics (ARQT) Could be Great Choice for a Bottom Fisher - MSN

Feb 12, 2025

Feb 12, 2025

Arcutis Biotherapeutics executive sells shares worth $153,873 By Investing.com - Investing.com Nigeria

Feb 12, 2025

Feb 11, 2025

Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Down 7.7%Here's What Happened - MarketBeat

Feb 11, 2025

Feb 11, 2025

Chronic Plaque Psoriasis Market Expected to rise, 2034 | - openPR

Feb 11, 2025

Feb 10, 2025

Trend Tracker for (ARQT) - Stock Traders Daily

Feb 10, 2025

Feb 10, 2025

4 Analysts Have This To Say About Arcutis Biotherapeutics - Benzinga

Feb 10, 2025

Feb 10, 2025

Chronic Plaque Psoriasis Treatment Market Size Report 2034 | - openPR

Feb 10, 2025

Feb 09, 2025

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Insider Masaru Matsuda Sells 8,338 Shares - MarketBeat

Feb 09, 2025

Feb 08, 2025

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Director Howard G. Welgus Sells 10,000 Shares - MarketBeat

Feb 08, 2025

Feb 07, 2025

Arcutis Biotherapeutics exec sells $27,597 in stock - MSN

Feb 07, 2025

Feb 07, 2025

Arcutis Biotherapeutics' senior VP Matsuda sells $105,892 in stock - MSN

Feb 07, 2025

Feb 07, 2025

Have Insiders Sold Arcutis Biotherapeutics Shares Recently? - Simply Wall St

Feb 07, 2025

Feb 06, 2025

Arcutis director Howard G. Welgus sells $127,100 in common stock - MSN

Feb 06, 2025

Feb 06, 2025

Jennison Associates LLC Raises Stock Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) - MarketBeat

Feb 06, 2025

Feb 06, 2025

Arcutis Biotherapeutics executive sells shares worth $153,873 - MSN

Feb 06, 2025

Feb 06, 2025

Arcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains. - Yahoo

Feb 06, 2025

Feb 06, 2025

Arcutis Biotherapeutics CEO Todd Watanabe sells $245,122 in shares - MSN

Feb 06, 2025

Feb 06, 2025

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Feb 06, 2025

Feb 05, 2025

Arcutis director Howard G. Welgus sells $127,100 in common stock By Investing.com - Investing.com South Africa

Feb 05, 2025

Feb 05, 2025

Insider Sell: Howard Welgus Sells 10,000 Shares of Arcutis Bioth - GuruFocus.com

Feb 05, 2025

Feb 05, 2025

Arcutis Biotherapeutics' senior VP Matsuda sells $105,892 in stock By Investing.com - Investing.com Australia

Feb 05, 2025

Feb 05, 2025

Arcutis Biotherapeutics exec sells $27,597 in stock By Investing.com - Investing.com Canada

Feb 05, 2025